Gerald T. Nepom
Chair of Autoimmune & Infectious Disease Scientific Advisory BoardDr. Gerald T. Nepom, also known as Jerry, M.D., Ph.D., serves as Director of the NIAID-sponsored Immune Tolerance Network (ITN). He serves as Senior Advisor at Frazier Life Sciences Management, LP, which he joined in 2025. He serves as Senior Advisor at Frazier Management, L.L.C., which he joined in 2025. Dr. Nepom serves as Member of the Advisory Board at Seismic Therapeutic, Inc. since March 2025. He serves as Member of the Scientific Advisory Board at Mozart Therapeutics, Inc. since October 2023 and as Member of the Scientific Advisory Board at Repertoire Immune Medicines, Inc. since 2023. He serves as Chair of the Autoimmune & Infectious Disease Scientific Advisory Board at NexImmune, Inc. since January 2022 and as Member of the Scientific Advisory Board at Rubius Therapeutics, Inc. since May 2021. He also serves as Member of the Clinical & Scientific Advisory Board at Accelerator Life Science Partners, Member of the Clinical Advisory Board at Airmid Incorporated, and Member of the Clinic Advisory Board at SEKRIS Biomedical, Inc. He served as Member of the Abata Advisory Board at Abata Therapeutics, Inc. from April 2022 to 2024. He is Founder of the Benaroya Research Institute at Virginia Mason (BRI) and also served as Director. Dr. Nepom served as President of the Federation of Clinical Immunology Societies (FOCIS). He also served as Faculty at the Fred Hutchinson Cancer Research Center and at the University of Washington School of Medicine. Additionally, he served as Member of the Scientific Advisory Board at Adaptive Biotechnologies Corporation, Aptevo Research and Development LLC, Converge Medical, Inc., and Xcyte Therapies Inc., and as Member of the Type 1 Diabetes Scientific Advisory Board at Lisata Therapeutics, Inc. Dr. Nepom has served in academic and executive leadership roles for several years with a focus on immunology, autoimmunity, and immunotherapy research. He has published numerous scientific papers on human immunology, genetics, and autoimmune disease with a focus on T cell immunobiology, disease susceptibility and pathogenesis. Dr. Nepom received a B.A. in Biochemistry from Harvard University in 1972, a Ph.D. in Biochemistry from the University of Washington in 1977, and an M.D. from the University of Washington in 1978.
Positions
- Company NameNexImmune, Inc.Stock CodeNEXIPositionChair of Autoimmune & Infectious Disease Scientific Advisory BoardColleagues
- JTJohn TrainerConsultant
- JSJonathan SchneckCo-Chairman of Scientific Advisory Board
- KHKaren HaslbeckHead of Human Resources
- DPDaniel P. BednarikSenior Vice President of Molecular Engineering & Protein Design
- RDRobert Douglas KnightChief Medical Officer
- CRChad RubinSenior Vice President of Corporate Affairs
- JSJeffrey S. WeberChief Scientific Advisor, Co-Chairman of Scientific Advisory Board and Member of AI & ID SAB
- MPMiguel-Angel PeralesMember of Scientific Advisory Board
- JVJuan VarelaMember of Scientific Advisory Board
